[Gallbladder cancer staging with 18F-FDG PET-CT].
Gallbladder cancer is the most common biliary tract neoplasm. It generally affects the elderly, who are usually clinically asymptomatic. When symptoms appear, they suggest the presence of complications locally or due to tumour progression. Late diagnosis of the disease indicates a poor prognosis for these patients. Surgery is the only treatment with curative intent, but it is only possible in the early stages. Diagnostic imaging of this type of tumour is usually performed with ultrasonography, computed tomography or magnetic resonance cholangiography. Positron emission tomography (PET) with fluorodeoxyglucose (FDG) with dedicated scanners or hybrid PET-CT scans are new diagnostic tools which could help in the pre-surgical diagnosis of these tumours. We present three cases to illustrate the usefulness of PET-FDG in the pre-surgical staging of gallbladder cancer.
Ramos-Font
C
C
Servicio de Medicina Nuclear, Hospital Universitario Virgen de las Nieves, Granada, Spain. carlos.ramos.font.ext@juntadeandalucia.es
Santiago Chinchilla
A
A
Rodríguez-Fernández
A
A
Rebollo Aguirre
A C
AC
Gómez Río
M
M
Llamas Elvira
J M
JM
D000230:Adenocarcinoma / Q000150:complications / Q000000981:diagnostic imaging* / Q000188:drug therapy / Q000473:pathology / Q000601:surgery; D000368:Aged; D000970:Antineoplastic Agents / Q000627:therapeutic use; D001943:Breast Neoplasms; D002763:Cholecystectomy; D002769:Cholelithiasis / Q000150:complications; D003131:Combined Modality Therapy; D003841:Deoxycytidine / Q000031:analogs & derivatives / Q000627:therapeutic use; D005260:Female; D005462:Fluorine Radioisotopes; D019788:Fluorodeoxyglucose F18; D005706:Gallbladder Neoplasms / Q000150:complications / Q000000981:diagnostic imaging* / Q000188:drug therapy / Q000473:pathology / Q000601:surgery; D006801:Humans; D008099:Liver / Q000000981:diagnostic imaging / Q000473:pathology; D009361:Neoplasm Invasiveness / Q000000981:diagnostic imaging; D009367:Neoplasm Staging / Q000379:methods*; D016609:Neoplasms, Second Primary / Q000000981:diagnostic imaging; D049268:Positron-Emission Tomography; D011300:Preoperative Care; D019275:Radiopharmaceuticals; D000093542:Gemcitabine
D000970:Antineoplastic Agents; D005462:Fluorine Radioisotopes; D019275:Radiopharmaceuticals; D003841:Deoxycytidine; D019788:Fluorodeoxyglucose F18; D000093542:Gemcitabine